Qilu Pharmaceutical Co., Ltd.

This study tests a new drug called QL1706 combined with chemotherapy for people with advanced non-small cell lung cancer that does not have the PD-L1 protein. About 606 adults will be randomly assigned to receive either QL1706 with chemo or another drug (tislelizumab) with chemo.…

This study tests a new drug called QL2106 against an approved drug, Tremfye®, in 190 healthy adults aged 18-45. The goal is to compare how the body processes each drug, their safety, and any immune reactions. Participants receive a single dose and are monitored closely. This is a…

This study tests whether a new fertility drug (QL1012D) works like an already approved drug (Gonal-F) in 48 healthy women aged 18-45. Participants receive both drugs at different times to compare how the body processes them and check for side effects. The goal is to see if the ne…